Entyvio 300 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FDJH7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,642
Award facts
- Contract value 100% obligated
- $14,642.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,642.04 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Entyvio 300 mg vials. The contract is classified as a firm fixed-price delivery order with an ultimate completion date of December 23, 2025, and was issued without set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award falls under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which carries a ceiling value of $499.999 billion and runs through December 31, 2036.
DMS Pharmaceutical Group serves as a critical regional pharmaceutical supplier supporting Department of Defense healthcare operations through the PPV-G GEN V program, a $30.3 billion acquisition strategy designed to provide military healthcare facilities worldwide with comprehensive pharmaceutical products including branded and generic prescription drugs, biologics, and medical consumables. The company's established performance on numerous delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division demonstrates its capability to fulfill the diverse and specialized pharmaceutical requirements of the federal military medical system. As a long-standing federal contractor registered in the System for Award Management since 2001, DMS Pharmaceutical Group has maintained consistent contract performance across multiple therapeutic categories and product lines serving Department of Defense medical supply needs.
Quick answers
Who was awarded contract SPE2DR26FDJH7?
SPE2DR26FDJH7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26FDJH7 worth?
The government has obligated $14,642 on SPE2DR26FDJH7.
Is contract SPE2DR26FDJH7 an order under another contract?
Yes. SPE2DR26FDJH7 is a delivery order under SPE2DR25D9144, an indefinite delivery contract.
Was contract SPE2DR26FDJH7 competed?
The extent of competition for SPE2DR26FDJH7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award